Skip to main content

Animations

Illustrated close up of DNA.

Research Tools Catalog

To save researchers time and resources, The Michael J. Fox Foundation has made a number of tools available to the scientific community at low cost, with rapid delivery.

Helpful Resources

  • Illustrated adjacent hexagons.

    Sponsored Tools Program

    Learn more about how MJFF can help share your tools.

  • Illustrated Parkinson's Disease Research Tools Consortium logo.

    Tools Consortium

    MJFF is working with industry to develop priority tools.

  • Illustrated brain on a presentation display.

    Preclinical Models

    Learn more about the various in vivo models used in Parkinson's disease research.

Find a Research Tool

Filter by Tool Type or Gene/Protein Type to Organize Results

* = MJFF does not control pricing or terms of availability for this tool. 

Filters
Sort by
Order
Filters
Sort by
Order
Sort by
Order
Results (357)
Sort by:
Miro1 Antibody (ELISA-Capture)
Antibody
Rabbit monoclonal antibody directed against human/mouse/rat Miro1, validated for use as a capture antibody in immunoassay applications.  Can also be purchased as a pair with the detector antibody here
  • Miro1
Miro1 Antibody (ELISA-Detector)
Antibody
Rabbit monoclonal antibody directed against human/mouse/rat Miro1, validated for use as a detector antibody in immunoassay applications.  Can also be purchased as a pair with the detector antibody here
  • Miro1
Human Alpha-Synuclein Monomer Protein for Making Pre-Formed Fibrils
Protein
Full-Length human alpha-synuclein monomeric protein specially formulated to generate pre-formed fibrils. These highly pure proteins are recommended for biochemical studies and can be used to form fibrils, but these fibrils have been found to lack seeding activity.  Note: A protocol for generating pre-formed fibrils from this monomeric protein will be included with each order.
  • Alpha-Synuclein
Mouse Alpha-Synuclein Monomer Protein for Making Pre-Formed Fibrils
Protein
Full-length mouse alpha-synuclein monomeric protein specially formulated to generate pre-formed fibrils. Please note, we recommend this protein for in vitro studies but not for in vivo experiments (the protein is validated for pS129 alpha-synuclein pathology in vitro but in vivo validation failed as robust pS129 alpha-synuclein pathology was not observed). These highly pure proteins are recommended for biochemical studies and can be used to form fibrils, but these fibrils have been found to lack seeding activity. Note: A protocol for generating pre-formed fibrils from this monomeric protein will be included with each order. 
  • Alpha-Synuclein
Alpha-Synuclein A53T Knockin Rat
Rat Model
CRISPR/Cas9 genome targeting strategy to knockin humanized amino acids for A53T on a Sprague Dawley rat aSyn KO background. RRID:RGD_13782163 Generated as part of the Industry Tools Consortium. 
  • Alpha-Synuclein
Floxed S69R Rab32 Mouse
Mouse Model
Mouse expressing the S69R point mutation in the mouse Rab32 gene (corresponds to the S71R mutation in human Rab32). LoxP sites flank the Rab32 gene to enable conditional Cre-mediated knockout.  Estimated Availability: Early 2026
  • Rab
Rab 10 Protein
Protein
Rab10 synthetic protein fragment (AA66-181) generated by native chemical ligation of recombinant peptides. To be used as a control with the pT73 Rab1o protein. This protein was designed and generated by X'PROCHEM.
  • Rab
Rab 12 Antibody (IP)
Antibody
Rabbit monoclonal antibody directed against human Rab 12. Suitable for use in immunoprecipitation.  
  • Rab
LRRK2 KO Rat
Rat Model
CRISPR/Cas9 genome targeting strategy to knockout LRRK2 on a Sprague Dawley rat background. Estimated Availability: Early 2026
  • LRRK2
Parkin KO Rat
Rat Model
CRISPR/Cas9 genome targeting strategy to knockout Parkin on a Sprague Dawley rat background. Estimated Availability: Late 2025
  • Parkin
Have questions or need additional information?

Email tools@michaeljfox.org with questions and to suggest new tools for us to develop. Or visit our FAQ page. 

"We have shown, thanks in part to MJFF, that researchers now have in their pantry the right ‘ingredients’, to... help to drive forward PD drug development.”
Heather Melrose, PhD Mayo Clinic
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.